7 Startups Applying AI To Drug Discovery - Disruption Hub

Exscientia is a UK startup founded in Oxford in 2012. It claims to be the first company to automate drug design with an artificially intelligent platform augmented with knowledge from human'drug hunters'. In 2017, Exscientia announced a strategic research collaboration with Sanofi to discover and develop therapies for metabolic diseases like diabetes. Metabolic diseases are difficult to find treatments for as they often lack single targets that respond well to drugs. Exscientia's AI platform addresses this issue by identifying and validating combinations of drug targets that could work together.